Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor vascular endothelium comprises morphologically and functionally distinct endothelial cells critical for cancer progression via disordered angiogenesis, increased permeability/leakiness, facilitation of metastasis, immune modulation, and therapy resistance—all driven predominantly by aberrant signaling pathways such as those involving VEGF-A.
Inhibition of angiogenesis, normalization of existing vasculature, enhancement of chemotherapy delivery
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Vascular Endothelium (TECs).